What You Should Know:
- Senseonics Holdings, a medical technology company specializing in implantable continuous glucose monitoring (CGM) systems, has announced a Memorandum of Understanding (MOU) with Ascensia Diabetes Care to transition all global commercialization and distribution of its Eversense 365 and future products to Senseonics. Since 2020, Ascensia, a member of PHC Group, has held the exclusive worldwide distribution rights for Eversense products.
This strategic move is
Read More
Impact of Diabetes Management for Patients, Payers, and Providers| News, Policy, Analysis, Insights - HIT Consultant
Reach7 Diabetes Studios and Trileas Partner to Launch CARES Program for At-Risk Communities
What You Should Know:
- Reach7 Diabetes Studios has announced that Trileas is the first official sponsor and founding member of its CARES Program. The program is a third-party sponsored initiative that provides screenings for high-risk individuals and subsidized memberships for those most in need.
- The partnership with Trileas, a company dedicated to delivering affordable connectivity and healthcare solutions, will help the CARES Program reach further, expand access, and transform
Read More
Carna Health & Siemens Healthineers Partner to Advance AI-Powered CKD Screening
What You Should Know:
- Carna Health, a digital health company focused on kidney care, has announced a strategic agreement with Siemens Healthineers. The collaboration aims to accelerate the adoption of Carna's AI-enabled chronic kidney disease (CKD) platform and bring point-of-care testing systems to emerging markets.
- This will help improve early detection and CKD management for high-risk and underserved populations by integrating Carna Health’s digital platforms with Siemens
Read More
FriskaAi Integrates with Dexcom’s CGM Data for AI-Powered Diabetes Management
What You Should Know:
- FriskaAi, an AI-powered healthcare platform, has announced an agreement with Dexcom, Inc., a global leader in glucose biosensing, to integrate data from Dexcom G7 and Dexcom G6 Continuous Glucose Monitoring (CGM) Systems into its platform.
- The collaboration will enable FriskaAi to use continuous glucose data to support physicians and patients with actionable, personalized care management programs.
Physician-Directed Platform for Chronic Disease
Read More
Advancing Diabetes Care: Combating Burnout and Harnessing Technology
As healthcare providers, we find ourselves at an exciting crossroads in diabetes management. Rapid advancements in technology—from remote patient monitoring to artificial intelligence—have fundamentally altered how we approach patient care. Yet, despite these technological leaps, a critical ingredient remains consistently underrepresented: the clinician’s voice, and the voices of people with diabetes.For nearly two decades as a pediatric endocrinologist, I've witnessed firsthand the immense
Read More
Diabetology Officially Established as a Specialty with Taxonomy Code
What You Should Know:
- The American College of Diabetology (ACD) announced that Diabetology has received formal recognition through the assignment of a unique taxonomy classification.
- The historic milestone affirms the specialized expertise of physicians who focus exclusively or primarily on diabetes care.
Diabetology: A Unique and Focused Specialty
Diabetology is defined as the specialty focused on the full continuum of diabetes care. This encompasses diagnosis,
Read More
Trinity Biotech Unveils CGM+: AI-Native Wearable Biosensor for Holistic Health Monitoring
What You Should Know:
- Trinity Biotech, a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, today unveiled its new flagship product, CGM+, a next-generation wearable biosensor platform designed for the $260 billion AI wearables market.
- Now in the later stages of device development, CGM+ is Trinity’s new AI-native continuous glucose monitoring (CGM) system, combining multi-sensor data and real-time analytics to meet the
Read More
Fruit Street Health Cleared: SEC Investigation Concludes with No Action
What You Should Know:
- Fruit Street Health announced that it has received a letter from the Securities and Exchange Commission ("SEC") confirming the conclusion of the SEC's investigation into the company. The letter states that the SEC enforcement staff does not intend to recommend any action by the SEC against Fruit Street Health.
- This announcement allows Fruit Street Health to continue its focus on its public benefit mission: serving the 1 in 3 Americans with prediabetes and
Read More
Tandem’s t:slim X2 Insulin Pump Now Integrates with Abbott’s FreeStyle Libre 3 Plus Sensor
What You Should Know:
- Tandem Diabetes Care, an insulin delivery and diabetes technology company, today announced that its Tandem t:slim X2™ insulin pump with Control-IQ+ automated insulin delivery (AID) technology now works with Abbott’s FreeStyle Libre® 3 Plus continuous glucose monitoring (CGM) sensor.
- The company has initiated an early access program in the United States and intends to scale availability in the second half of 2025.
Expanding Patient Choice and
Read More
Rimidi Partners with Quest Health to Improve Blood Glucose for Diabetes Patients via RPM
What You Should Know:
- Quest Health Solutions, a national leader in diabetes care, today announced compelling results from its Remote Patient Monitoring (RPM) program, developed in partnership with the digital health company Rimidi. In just two months, the Quest Health RPM Services—powered by Rimidi's EHR-integrated platform—led to an 11% improvement in average blood glucose readings among participating patients.
- The collaboration highlights the power of combining
Read More
